Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
American, biology, blockage, complex, conclusively, eighteen, elastin, evidenced, evolve, exhibited, induced, intermediate, master, modulate, pembrolizumab, simultaneously, Society, survival, synergistic, synergistically, underlying
Removed:
antifibrotic, commencement, contemplate, daily, filer, goal, initiate, made, PDGF, predicted, quality, resulted
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view